Vemedia Consumer Health is pleased to announce the acquisition of Stardea, a fast growing Consumer Healthcare company in Italy. Financial terms are not disclosed. The acquisition of Stardea follows the acquisition of Oenobiol earlier this month.
Stardea, headquartered in Parma (Italy) is specialized in the development, marketing & sales and distribution of nutraceutical products. The company has a solid growth record and achieved a turnover of € 12 million in 2015. The company is mainly active in Italy.
Yvan Vindevogel, Executive Chairman of the Board says : “The Stardea acquisition is the second important acquisition for Vemedia this year. Combining Stardea’s salespower and extensive range of neutraceutical products with Vemedia’s strong brands will be beneficial for Vemedia’s strong position on the Italian market. In the future, Vemedia will support Stardea to further develop and launch innovative concepts and products. ”
Rob Drenth, CEO of the Vemedia Group says: “ Stardea regularly visits 40.000 physicians with teams of medical reps, with an extensive range of products in various categories. These focused teams are a true asset for Vemedia. We are convinced that we will be able to continue the success story of Stardea in Italy. Moreover, Vemedia will benefit from the additional support given by the sales teams of Stardea and even accelerate its growth path.”